Recent Quotes (30 days)

You have no recent quotes
chg | %

Noveko International Inc.  

(Public, TSE:EKO)   Watch this stock  
Find more results for EKO
0.00000
- Close
TSE data delayed by 15 mins - Disclaimer
Currency in
Range     -
52 week 0.03 - 0.17
Open     -
Vol. 0.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -0.17
Shares 99.51M
Beta     -
Inst. own     -

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin -588.30% -125.52%
Operating margin -352.75% -116.09%
EBITD margin - -78.40%
Return on average assets -42.92% -51.65%
Return on average equity -145.43% -79.74%
Employees 152 -
CDP Score - -

Address

Suite 300, 1190, Place Nobel
BOUCHERVILLE, QC J4B 5L2
Canada
+1-514-8750606 (Phone)
+1-514-8750660 (Fax)

Website links

Description

Noveko International Inc. (Noveko International) is a Canada-based company. The Company offers solutions in the environmental and medical fields worldwide. Noveko International, through its subsidiaries, is engaged in the design, development, manufacture and marketing of derivative products from its air filtration technologies, hand sanitizers with antimicrobial properties and medical equipment, including ultrasound scanners for human and veterinary medicine. Noveko Inc. develops Noveko antimicrobial surgical masks, respirators and air filters derived from its antimicrobial filtration technology. It also develops antiseptic hand sanitizers sold under the Microban brand. Noveko surgical masks and respirators incorporate its technologies with antimicrobial agents preventing the growth of a broad spectrum of micro organisms. On April 2, 2010, it acquired 100% interest in Noveko (Beijing) Hi-Tech Development Limited. In March 2012, it sold its subsidiary Bolduc Leroux Inc.